TRML (Tourmaline Bio Inc) Sof foyda

TRML (Tourmaline Bio) - kompaniyaning tovar belgisi

Tourmaline Bio, Inc. (TRML) — bu antitanachlar ishlab chiqarishini uchinchi tomon pudratchilariga topshiradigan aktivlar kamligi modelidan foydalanuvchi biotexnologiya kompaniyasidir. GURU.Markets grafigidagi narxlar tarixi, u yerda ko'rsatkich -0.09 darajasida turibdi, aktivning dinamikasini aks ettiradi. Biznes hozirda qarz kapitaliga tayanib, yangi dori vositalarini sinovdan o'tkazishga ulkan mablag'lar sarflamoqda. Shu bilan birga, firma sanoat gigantlarining kengayishi va generik dori vositalari tufayli terapiya qiymatining pasayishi xavfi bilan kurashishi kerak.

TRML (Tourmaline Bio, Inc.) Sof foyda tarixi 21.02.2024dan 08.11.2025gacha

Tourmaline Bio (TRML) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari Tourmaline|TRML - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor kapitallashuvi Tourmaline|TRML - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Aksiyaning buxgalteriya qiymati Tourmaline Bio|TRML - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi tourmalinebio.com|TRML - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Tourmaline Bio, Inc.|TRML - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Tourmaline Bio Inc|TRML - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Tourmaline|TRML - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Tourmaline Bio|Shoshilinch likvidlik tourmalinebio.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
TRML - Sof daromad
Kompaniyaning jamlanma tahlili:Tourmaline Bio, Inc.
Tourmaline Corp asosiy tovari

Tourmaline Bio, Inc. (TRML) oftalmologiya va kardiologiyadagi noelast talabga ega terapiyalar uchun IL-6 antitanachalarini qayta yo'naltirishga ixtisoslashgan. Ushbu ko'rsatkich bozor kuchlarining yakuniy balansini aks ettiruvchi aksiya boshiga sof foydani aniqlaydi. Investorlar uchun ushbu metrikani kelajakdagi narx belgilash imkoniyatlari uchun monetizatsiya strategiyasining samaradorligini tasdiqlovchi omil sifatida baholash juda muhimdir. Ijobiy tendentsiya fundamental qiymatning oshishidan dalolat beradi. Kompaniyaning moliyaviy natijalari dinamikasi sanoat sikli bosqichini o'z vaqtida aniqlash imkonini beradi.

Asosiy raqobatchilar

Sof daromad argenx BVBA|BNTX (BioNTech SE) - Sof foyda|Sof foyda Abivax Pharma|Sof daromad ADMA (ADMA Biologics, Inc.)|PTGX (Protagonist Therapeutics, Inc.) - Yakuniy foyda|Sof foyda IMVT (Immunovant Corp)|Sof moliyaviy natija Kiniksa Corp (KNSA)|GRFS - Kompaniyaning sof foydasi|adaptivebiotech.com (ADPT) - Sof daromad|Celldex Therapeutics, Inc. (CLDX) - Kompaniyaning sof foydasi|Sof daromad Aurinia Pharmaceuticals Inc|Sof daromad BCRX|Sof foyda Vera Corp|Kompaniyaning sof foydasi Dianthus Therapeutics (DNTH)|pharvaris.com - Kompaniya foydasi|Sof foyda ABCL (AbCellera Biologics Inc)|Precigen Inc (PGEN) - Kompaniyaning sof daromadi|PHAR: Sof daromad|Nektar Corp - Soliqlar to‘langandan keyingi foyda|Upstream Bio Inc (UPB) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi zenasbio.com (ZBIO)|Sof daromad IMNM|Sof foyda Gossamer Bio Inc|Kompaniyaning sof foydasi KalVista Pharmaceuticals Inc (KALV)|SEPN (Septerna Pharma) - Yakuniy foyda|Kompaniyaning sof foydasi Pieris Pharmaceuticals PVLA|SVRA - Sof daromad|Rigel Pharmaceuticals, Inc. - Sof foyda|ANAB - Sof foyda|Astria Pharma (ATXS) - Kompaniyaning sof foydasi|ENGN (enGene Corp) - Kompaniyaning sof foydasi|RAPT (RAPT Therapeutics, Inc.) - Sof foyda|Aerovate (JBIO) - Sof moliyaviy natija|Kompaniyaning sof foydasi Aclaris Therapeutics, Inc. (ACRS)|Kyverna Therapeutics Inc. - Kompaniya foydasi|Sof foyda TLSA (Tiziana Life Sciences PLC)|Cabaletta Bio Inc (CABA) - Kompaniyaning sof daromadi|VTYX: Sof daromad|Yakuniy foyda THTX (theratech.com)|AVTX: Sof foyda|ELDN (Eledon Pharmaceuticals Inc.) - Kompaniyaning sof foydasi|AGEN (Agenus Inc) - Sof foyda|Climb Bio, Inc (CLYM) - Sof moliyaviy natija|Kompaniyaning sof foydasi Zura Bio Limited (ZURA)|ATYR - Kompaniyaning sof daromadi|Adagene Inc. - Sof daromad|Yakuniy foyda IMA|Shattuck Therapeutics - Sof foyda|Sof moliyaviy natija Equillium, Inc. EQ|connectbiopharm.com (CNTB) - Kompaniyaning sof foydasi|Kompaniya foydasi IMUX|ATRA (Atara Biotherapeutics, Inc.) - Sof foyda|Sof daromad InflaRx GmbH (IFRX)|Sof daromad XFOR (X4 Pharma)|Sof moliyaviy natija adicetbio.com|Celularity - Sof daromad|Soliqlar to‘langandan keyingi foyda INMB (inmunebio.com)|BRNS - Kompaniyaning sof foydasi|Yakuniy foyda KZR (Kezar Life Sciences Inc.)|SAB Biotherapeutics, Inc (SABS) - Kompaniyaning sof foydasi|Sof daromad Akari Therapeutics, Plc|Kompaniyaning sof foydasi Enlivex Therapeutics Ltd|Kompaniyaning sof foydasi QTTB|Kompaniyaning sof foydasi GeoVax (GOVX)|EDSA: Soliqdan keyingi foyda|Sof foyda IBIO (iBio Corp)|Yakuniy foyda CARM|XTL Biopharmaceuticals - Sof foyda|BOLT - Sof foyda|hcwbiologics.com (HCWB) - Kompaniyaning sof foydasi|Aptevo Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi AIM ImmunoTech|Sof daromad Aditxt Corp (ADTX)|Sof foyda GRI|Sof foyda xortx.com (XRTX)|Vyome Holdings - Sof daromad|Yakuniy foyda REVB|Indaptus - Sof foyda|Sof moliyaviy natija BiondVax Pharmaceuticals SCNI|calcimedica.com (CALI) - Kompaniyaning sof foydasi|Sof daromad Affimed N.V.|Kompaniyaning sof foydasi Allakos Inc|Sof daromad HOOKIPA (HOOK)|Sof daromad IGMS (IGM Biosciences, Inc.)|Sof foyda iTeos Pharma (ITOS)|Kompaniyaning sof foydasi Ocean Biomedical, Inc. OCEA|TCBP: Kompaniya foydasi|Third Harmonic Bio, Inc. - Sof foyda